ANTOLRX

At AnTolRx they are approaching the treatment of autoimmune diseases differently–through the development of novel nanoparticle-based therapies to promote antigen-specific immune tolerance. Standard therapies broadly suppress the immune system, inducing side effects that may include life threatening infections and tumors. Thus, there is an unmet clinical need for methods of targeted immune-regulation. Their proprietary drug development approach selectively targets pathogenic immune cells providing a unique tolerogenic signal to induce an anti-inflammatory phenotype and better treat diseases.

#People #Financial #Website #More

ANTOLRX

Industry:

Biotechnology Health Care

Founded:

2015-01-01

Address:

Cambridge, Massachusetts, United States

Country:

United States

Website Url:

http://www.antolrx.com

Total Employee:

11+

Status:

Active

Contact:

(617)945-8468

Email Addresses:

[email protected]

Total Funding:

4 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Google Tag Manager WordPress Google Universal Analytics Apache

Current Advisors List

peter-lomedico_image

Peter Lomedico Member, AnTolRx Board of Directors @ AnTolRx
Board_member
2016-12-01

satish-jindal_image

Satish Jindal Board of Directors @ AnTolRx
Board_member

Current Employees Featured

daniel-geffken_image

Daniel Geffken
Daniel Geffken Interim Chief Financial Officer @ AnTolRx
Interim Chief Financial Officer
2016-06-01

mark-carthy_image

Mark Carthy
Mark Carthy Chairman @ AnTolRx
Chairman
2014-03-01

francisco-j-quintana_image

Francisco J Quintana
Francisco J Quintana Co Founder, Director @ AnTolRx
Co Founder, Director
2016-07-01

Founder

francisco-j-quintana_image

Francisco J Quintana

mark-carthy_image

Mark Carthy

satish-jindal_image

Satish Jindal

Investors List

jdrf_image

Official Site Inspections

http://www.antolrx.com

Host Informations
Whois Informations

Loading ...